Science
Pfizer says its coronavirus vaccine is over 90% effective
However, Monday's announcement doesn't mean a vaccine is imminent
Bharat Biotech to launch Covaxin in second quarter of 2021
The price of the vaccine is yet to be determined, as the company is still looking at the cost of product development
Coronavirus developing genetic mutations, turning more contagious: Study
The research, published in the journal mBIO, however, did not find that these mutations have made the virus deadlier
Fake asteroid? NASA expert IDs mystery object as old rocket
The rocket swept past the moon and into orbit around the sun as intended junk, never to be seen again — until perhaps now
Australian study finds coronavirus can last 28 days on glass, currency
Findings from the study show that in a very controlled environment the virus remains infectious for longer than other studies have found
Coronavirus can survive on skin for 9 hours: Study
The study found that virus was inactivated more rapidly on skin surfaces than on other surfaces such as stainless steel, glass and plastic
Trio win Nobel Physics Prize for black hole research
In-person ceremony has been cancelled this year due to the coronavirus pandemic, replaced with a televised ceremony
New testing method can diagnose COVID-19 in just 30 minutes, study finds
The virus can be detected immediately without any preparation process with high sensitivity in a short time
3 win Nobel medicine award for Hepatitis C virus discovery
The medicine prize carries particular significance this year due to the pandemic, which has highlighted the importance that medical research
Covaxin to use ViroVax's adjuvant Alhydroxiquim-II to boost immune response
Bharat Biotech is currently conducting Phase II human trials of Covaxin after receiving approval from the Drug Controller General of India